Circle Pharma, Inc. — Form D/A

Circle Pharma, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2022-03-22. The offering totals $66.3M, of which $66.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
David EarpDirectorSouth San Francisco, CA
James EvangelistaDirectorSouth San Francisco, CA
Matthew JacobsonDirectorSouth San Francisco, CA
Walter MoosDirectorSouth San Francisco, CA
Thilo SchroederDirectorGrand Duchy of Luxembourg, N4
David EarpExecutive OfficerSouth San Francisco, CA
Elton SatuskyExecutive OfficerPalo Alto, CA
Peter SvennilsonDirectorSouth San Francisco, CA
Thilo H SchroederDirectorSOUTH SAN FRANCISCO, CA
Stephen H KelseyDirectorSOUTH SAN FRANCISCO, CA
David J EarpDirectorSOUTH SAN FRANCISCO, CA
David J EarpExecutive OfficerSOUTH SAN FRANCISCO, CA
Matthew P JacobsonDirectorSOUTH SAN FRANCISCO, CA
Walter H MoosDirectorSOUTH SAN FRANCISCO, CA
Paul H ParkExecutive OfficerSOUTH SAN FRANCISCO, CA
James H EvangelistaDirectorSOUTH SAN FRANCISCO, CA
John JoseyDirectorSOUTH SAN FRANCISCO, CA
Elton J SatuskyExecutive OfficerPalo Alto, CA
John P JoseyDirectorSouth San Francisco, CA
Thilo P SchroederDirectorSouth San Francisco, CA
Peter P SvennilsonDirectorSouth San Francisco, CA
Cayla J McEwenExecutive OfficerSouth San Francisco, CA
Walter P MoosDirectorSouth San Francisco, CA
Scott R LokeyDirectorSan Francisco, CA
Douglas R CrawfordDirectorSan Francisco, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2025-01-10D/A$117.4M$92.4M
2024-08-29D/A$117.4M$63.2M
2024-07-03D$117.4M$54.2M
2021-06-29D$66.3M$35.7M
2020-03-23D$45.0M$15.0M
2016-09-09D$6.0M$3.8M

More